The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...
Health and Me on MSN6d
GLP-1 Drugs Could Be Used To Treat Chronic Kidney DiseaseA latest research led by Dr Shuyao Zhang, an assistant professor of internal medicine at UT Southwestern in Dallas reveal the ...
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...
The latest attempt focuses on liraglutide, an older, once-daily injectable product in Novo Nordisk's GLP-1 agonist franchise sold as Victoza and Xultophy for diabetes and Saxenda for obesity.
The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people ... on the market as Victoza for diabetes and Saxenda for obesity. It has been largely superseded ...
A 52-year-old man has knocked his decade-long cocaine addiction on the head after receiving weight-loss injections. The jab ...
Good Housekeeping UK on MSN5d
Weightloss drugs: five extra benefits for your healthYes, weightloss drugs can help you lose weight – but they can also boost your health in unexpected ways. Good Housekeeping’s ...
WEIGHT loss jabs slash alcohol cravings and can curb dangerous binge drinking, new research suggests. The active drug ...
Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback